ReviewCurrent gastroenterology reports2025
Portal Hypertensive Colopathy: Diagnostic Challenges and Management in Cirrhosis.
Review in Current gastroenterology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Advances in the diagnosis and treatment of portal hypertensive gastrointestinal and bile duct disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review summarizes the current understanding of portal hypertensive colopathy (PHC), highlights the clinical and endoscopic presentation, treatment options to be considered and areas for future investigation. RECENT
findingsPortal hypertensive colopathy (PHC) is an underrecognized consequence of portal hypertension in cirrhosis. It frequently presents with subtle gastrointestinal symptoms, such as iron deficiency anemia or intermittent rectal bleeding, and is often misattributed to more common etiologies like hemorrhoids or diverticular disease. PHC is a diagnosis made endoscopically and is characterized by erythema of the colonic mucosa, vascular lesions and colon varices. Management focuses on portal pressure reduction, endoscopic colon therapies and intra-vascular procedures. Due to a lack diagnostic criteria, the true prevalence of PHC is unknown but has been reported to be up to 71% among cirrhotic patients. The management of acute bleeding from PHC is based on case reports, case series and expert opinion. PHC should be considered in all cirrhotic patients with unexplained lower GI bleeding or chronic anemia. A high index of suspicion is required in order to make a timely and accurate diagnosis.
Indexed as
Identifiers
40971083What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.